Could US-Style Priority Review Vouchers Drive European Neglected Disease R&D?

 
• By Francesca Bruce

Having its own priority review vouchers could serve as an important pull incentive for neglected disease R&D in Europe, although the unpredictable nature of the vouchers may deter some investors.

Diseases traditionally found in the developing world are increasingly present in Europe thanks to factors such as climate change. • Source: Shutterstock

More from Europe

More from Geography